Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.
Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at advancing the field of synthetic biology. This ...
Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at ...
Nanocarriers enhance peptide and oligonucleotide therapy by improving stability, bioavailability, and targeted delivery for effective clinical applications.
Yonsei University researchers have developed a system for combining the benefits of planar array platforms with those of ...
The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...
IDT's suite of NGS innovations aim to tackle longstanding bottlenecks in library preparation, targeted enrichment, and whole genome analysis.
REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of ...
Abstract: Oligo DNA microarrays are fabricated through in-situ chemical synthesis. Contact and fluid dynamics all contribute to this process. To produce high quality oligo DNA microarrays, it is ...
The DNA Synthesis Market is entering a powerful growth phase as genetic research, biotechnology, diagnostics, and therapeutic innovation converge globally. According to industry projections, the DNA ...
RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging from rare genetic disorders to widespread chronic illnesses like diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results